lilly tirzepatide lawsuit The weight-loss drug wars just got a courtroom subplot. Novo Nordisk — the OG of GLP-1s — is suing Eli Lilly, alleging its rival's ads misleadingly claim Zepbound beats Wegovy. The catch? Mounjaro Lawsuit - July 2026

Consistent stimulus to preserve gains

Medications are very good at tackling that

When to Worry About Injection-Site Bruising Small bruises (under one inch) with no swelling, warmth, or tenderness are normal and fade within 710 days

The incidence of severe hypoglycemia in patients with type 2 diabetes was 5% at 26 weeks in patients receiving TOUJEO as part of a multiple daily injection regimen, and 1.0% and 0.9% respectively at 26 weeks in the two studies where patients received TOUJEO as part of a basal-insulin only regimen

Why vial size matters for your calculations Every reconstitution calculation starts with knowing exactly how much peptide you have